Michael Blute, Sr., MD, chief of the Department of Urology, answers questions about prostate health and what men can do to protect themselves and their loved ones.
Using new and sophisticated tools, experts at Mass General’s Pulmonary Nodule Clinic are detecting lung cancers earlier, when they are more curable.
Decades of work-related exposure to asbestos left Paul Pratt with a dangerous form of cancer and a mission to support the search for a cure.
The Liposarcoma Genome Project started with seed money from a patient donor. Now it is poised to take sarcoma research to an exciting new place.
Nearly 1,000 patients, caregivers, and friends gathered along Boston’s Charles River Esplanade for the Everyday Amazing Race, which raised funds for the Mass General Cancer Center.
Mass General’s director of Breast Imaging addresses confusion over mammograms and provides advice on when women should get one.
Inspired by the care she received at the Mass General Cancer Center, Anastasia Troubalos made a bequest that is supporting its efforts to develop groundbreaking therapies and continue providing exceptional care to patients.
Thanks to immunotherapy at Mass General, Steve Harvey has bounced back from multiple bouts with cancer to take part in the Mass General Cancer Center’s Everyday Amazing Race.
Cancer immunotherapy researchers at Mass General are identifying powerful new targets by using the immune system to fight cancer — bringing new hope to patients and changing the future course of cancer treatment.
For some time, there has been evidence to suggest a drug used to treat type 2 diabetes could slow certain types of cancers. Until now, we didn’t know why.